An Open-Label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine

This study has been terminated.

( This study was stopped prematurely due to lack of efficacy. )

Study NCT00165880 Information provided by Eisai Inc.

First Received: September 13, 2005 Last Updated: March 4, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2007
Estimated Primary Completion Date:	No date given